Cargando…
microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response
Sentinel node biopsy (SNB) is a main staging biomarker in melanoma and is the first lymph node to drain the tumor, thus representing the immunological site where anti-tumor immune dysfunction is established and where potential prognostic immune markers can be identified. Here we analyzed microRNA (m...
Autores principales: | Vallacchi, Viviana, Camisaschi, Chiara, Dugo, Matteo, Vergani, Elisabetta, Deho, Paola, Gualeni, Ambra, Huber, Veronica, Gloghini, Annunziata, Maurichi, Andrea, Santinami, Mario, Sensi, Marialuisa, Castelli, Chiara, Rivoltini, Licia, Rodolfo, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192500/ https://www.ncbi.nlm.nih.gov/pubmed/27983661 http://dx.doi.org/10.3390/genes7120124 |
Ejemplares similares
-
Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer
por: Camisaschi, Chiara, et al.
Publicado: (2016) -
Immune response markers in sentinel nodes may predict melanoma progression
por: Rodolfo, Monica, et al.
Publicado: (2014) -
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
por: Vergani, Elisabetta, et al.
Publicado: (2015) -
Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients
por: Vergani, Elisabetta, et al.
Publicado: (2021) -
microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy
por: Daveri, Elena, et al.
Publicado: (2020)